Xia Xu
Beijing, 100069, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
B1 cells drive pulmonary emphysema progression through ADAM10.
Journal: Respiratory research
Published: January 25, 2026
Postprandial parasympathetic signals promote lung type 2 immunity.
Journal: Neuron
Published: January 11, 2024
Correction: Eosinophils promote pulmonary matrix destruction and emphysema via Cathepsin L.
Journal: Signal transduction and targeted therapy
Published: November 27, 2023
MiR-23a-5p alleviates chronic obstructive pulmonary disease through targeted regulation of RAGE-ROS pathway.
Journal: Respiratory research
Published: November 09, 2023
Emodin-Based Nanoarchitectonics with Giant Two-Photon Absorption for Enhanced Photodynamic Therapy.
Journal: Angewandte Chemie (International ed. in English)
Published: June 07, 2023
Pulmonary rehabilitation restores limb muscle mitochondria and improves the intramuscular metabolic profile.
Journal: Chinese medical journal
Published: February 08, 2023
Eosinophils promote pulmonary matrix destruction and emphysema via Cathepsin L.
Journal: Signal transduction and targeted therapy
Published: December 15, 2022
CARD9 balances Aspergillus fumigatus-induced anti-fungal immunity and allergic inflammation.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: November 08, 2022
Heterozygous CARD9 mutation favors the development of allergic bronchopulmonary aspergillosis.
Journal: Chinese medical journal
Published: October 11, 2022
Super Light-Sensitive Photosensitizer Nanoparticles for Improved Photodynamic Therapy against Solid Tumors.
Journal: Angewandte Chemie (International ed. in English)
Published: July 25, 2022
The Heterogeneity of Inflammatory Response and Emphysema in Chronic Obstructive Pulmonary Disease.
Journal: Frontiers in physiology
Published: September 26, 2021
Last Updated: 09/26/2026